Biomedical polymers have been extensively developed for promising applications in a lot of
biomedical fields, such as therapeutic medicine delivery, disease detection and diagnosis …

The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

In patients with glioblastoma (GBM), upregulated midkine (MDK) limits the survival benefits
conferred by temozolomide (TMZ). RNA interference (RNAi) and CRISPR–Cas9 gene …

Natural killer (NK) cell therapies show potential for tumor treatment but are immunologically
resisted by the overexpressed immunosuppressing tumor cell surface glycans. To reverse …

Natural killer (NK) cells display a unique inherent ability to identify and eliminate virus-
infected cells and tumor cells. They are particularly powerful for elimination of hematological …

Combination chemotherapy refers to the use of multiple drugs to treat cancer. In this therapy,
the optimal ratio of the drugs is essential to achieve drug synergism and the desired …

Abstract The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-
associated protein 9 (Cas9) system holds great promise for the cancer gene therapy …

The emergence of immunotherapy for cancer treatment bears considerable clinical promise.
Nevertheless, many patients remain unresponsive, acquire resistance, or suffer dose …

Although nano-immunotherapy has advanced dramatically in recent times, there remain two
significant hurdles related to immune systems in cancer treatment, such as (namely) …

Free radical therapy based on 5‐aminolevulinic acid (ALA, a precursor of the
photosensitizer protoporphyrin IX (PpIX)) has been approved by the US Food and Drug …